Aclaris Share Price

Aclaris Share Price

NASDAQ: ACRS | Small Cap | Healthcare
$3.45
-$0.04 (-1.15%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Aclaris Stock Performance

Open
$3.48
Prev. Close
$3.49
Circuit Range
N/A
Day Range
$3.41 - $3.52
Year Range
$2.36 - $6.59
Volume
1,71,378
Average Traded
$3.46

Aclaris Share Price Today

As of 21 November 2026, Aclaris Therapeutics, Inc.'s share price is $3.45. The stock opened at $3.48, compared to its previous close of $3.49. During today's trading session, Aclaris Therapeutics, Inc.'s share price traded between $3.41 and $3.52, with an average price of $3.47. Over the past 52 weeks, the stock has recorded a high of $6.59 and a low of $2.36. In terms of performance, Aclaris Therapeutics, Inc.'s share price has declined by 24.26% over the last six months and is up 22.12% on a year-on-year basis.

Aclaris Share Price Chart

Line chart of the Aclaris price trend over the selected period. The price fell overall, ranging from 3.41 to 3.52, ending at 3.45.
$3.41$3.52
L
Show Current Price
H

Aclaris Stock Fundamentals & Key Indicators

Market Cap
$422.85M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.50
Revenue (TTM)
$7.83B
Return On Equity (TTM)
-47.74%
Profit Margin
-829.12%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
6.52%

Aclaris Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.30$2.00$1.63$1.48
Net Profit-$19.80-$19.82-$21.51-$18.51
Net Profit Margin-1523.08%-991.00%-1319.63%-1250.68%
Income ChangeN/A-0.10%-8.53%13.95%

Aclaris Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$29.75$31.25$18.72$7.83
Net Profit-$86.91-$88.48-$132.07-$64.92
Net Profit Margin-292.13%-283.14%-705.50%-829.12%
Income ChangeN/A-1.81%-49.27%50.84%

Aclaris Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets64.1494.3868.5523.05
Current Assets96.32125.95128.86231.55
Total Assets160.46220.33197.41254.6
Non Current Liabilities28.7333.189.2737.24
Current Liabilities28.6531.630.9519.74
Total Liabilities57.3864.7740.2356.98
Shareholders' Equity103.08155.55157.18197.62

Aclaris Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-47.11-20.08-78.33-72.27
Investing48.37-69.7746.2212.63
Financing-5.8674.5426.7177.57

About Aclaris

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

Aclaris Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.96
$3.45
-13.21%
Oct 2026
$5.17
$3.98
-24.57%
Sep 2026
$6.15
$5.27
-14.31%
Aug 2026
$5.12
$6.15
+18.38%
Jul 2026
$5.61
$5.20
-1.89%
Jun 2026
$4.52
$5.29
+16.25%
May 2026
$4.32
$4.55
+4.95%
Apr 2026
$3.82
$4.34
+15.73%
Mar 2026
$2.79
$3.75
+30.66%
Feb 2026
$3.44
$2.87
-18.23%
Jan 2026
$2.99
$3.51
+17.00%
Dec 2025
$2.76
$3.00
+6.19%

Aclaris Share Price FAQs